Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

Failures in Alzheimer's disease (AD) drug trials highlight the need to further explore disease mechanisms and alterations of biomarkers during the development of AD. Using cross‐sectional data from 377 participants in the BioFINDER study, we examined seven cerebrospinal fluid (CSF) and six plas...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:EMBO Mol Med
Autors principals: Palmqvist, Sebastian, Insel, Philip S, Stomrud, Erik, Janelidze, Shorena, Zetterberg, Henrik, Brix, Britta, Eichenlaub, Udo, Dage, Jeffrey L, Chai, Xiyun, Blennow, Kaj, Mattsson, Niklas, Hansson, Oskar
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6895602/
https://ncbi.nlm.nih.gov/pubmed/31709776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201911170
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars